Publications

 

Updated publication list November 2019

2019

  1. Xu-Monette ZY, Li J, Xia Y, Crossley B, Bremel RD, Miao Y, Xiao M, Snyder T, Manyam GC, Tan X, Zhang H, Visco C, Tzankov A, Dybkaer K, Bhagat G, Tam W, You H, Hsi ED, van Krieken JH, Huh J, Ponzoni M, Ferreri AJM, Møller MB, Piris MA, Winter JN, Medeiros JT, Xu B, Li Y, Kirsch I, Young KH. Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies. J Immunother Cancer. 2019 Oct 22;7(1):272. doi: 10.1186/s40425-019-0730-x. PubMed PMID: 31640780.
  2. Tøstesen M, Nørgaard M, Nørgaard JM, Medeiros BC, Marcher CW, Overgaard UM, Severinsen MT, Schoellkopf C, Østgård LSG. Longer distance to specialized treatment centers does not adversely affect treatment intensity or outcomes in adult acute myeloid leukemia patients. A Danish national population-based cohort study. Clin Epidemiol. 2019 Aug 28;11:769-780. doi: 10.2147/CLEP.S210456. eCollection 2019. PubMed PMID: 31695504; PubMed Central PMCID: PMC6718163.
  3. Lars B Nielsen, Rasmus F Brøndum, Martin Bøgsted. ccostr: An R package for estimating mean costs with censored data. Journal of open source software. 2019 Sep 5. The Journal of Open Source Software
  4. Vesteghem C, Brøndum RF, Sønderkær M, Sommer M, Schmitz A, Bødker JS, Dybkær K, El-Galaly TC, Bøgsted M. Implementing the FAIR Data Principles in precision oncology: review of supporting initiatives. Brief Bioinform. 2019 Jun 29. pii: bbz044. doi: 10.1093/bib/bbz044. [Epub ahead of print] PubMed PMID: 31263868.
  5. Mollerup S, Asplund M, Friis-Nielsen J, Kjartansdóttir KR, Fridholm H, Hansen TA, Herrera JAR, Barnes CJ, Jensen RH, Richter SR, Nielsen IB, Pietroni C, Alquezar-Planas DE, Rey-Iglesia A, Olsen PVS, De Meyts ER, Groth-Pedersen L, von Buchwald C, Jensen DH, Gniadecki R, Høgdall E, Langhoff JL, Pete I, Vereczkey I, Baranyai Z, Dybkaer K, Johnsen HE, Steiniche T, Hokland P, Rosenberg J, Baandrup U, Sicheritz-Pontén T, Willerslev E, Brunak S, Lund O, Mourier T, Vinner L, Izarzugaza JMG, Nielsen LP, Hansen AJ. High-throughput sequencing-based investigation of viruses in human cancers by multi-enrichment approach. J Infect Dis. 2019 Jun 28. pii: jiz318. doi: 10.1093/infdis/jiz318. [Epub ahead of print] PubMed PMID: 31253993.
  6. Madsen ML, Due H, Ejskjær N, Jensen P, Madsen J, Dybkær K. Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review. Cancer Chemother Pharmacol. 2019 Jun 18. doi: 10.1007/s00280-019-03884-5. [Epub ahead of print] Review. PubMed PMID: 31214762.
  7. Pálmarsdóttir R, Kiesbye Øvlisen A, Tang Severinsen M, Glimelius I, E Smedby K, El-Galaly T. Socioeconomic impact of Hodgkin lymphoma in adult patients: a systematic literature review. Leuk Lymphoma. 2019 Jun 6:1-16. doi: 10.1080/10428194.2019.1613538. [Epub ahead of print] PubMed PMID: 31167589.
  8. El-Galaly TC, Cheah CY, Villa D. Real world data as a key element in precision medicine for lymphoid malignancies: potentials and pitfalls. Br J Haematol. 2019 May 29. doi: 10.1111/bjh.15965. [Epub ahead of print] Review. PubMed PMID: 31140600.
  9. Gormsen LC, Vendelbo MH, Pedersen MA, Haraldsen A, Hjorthaug K, Bogsrud TV, Petersen LJ, Jensen KJ, Brøndum R, El-Galaly TC. A comparative study of standardized quantitative and visual assessment for predicting tumor volume and outcome in newly diagnosed diffuse large B-cell lymphoma staged with 18F-FDG PET/CT. EJNMMI Res. 2019 May 3;9(1):36. doi: 10.1186/s13550-019-0503-z. PubMed PMID: 31054023.
  10. Jakobsen LH, Biccler JL, Brown PN, Jørgensen JM, Josefsson PL, Poulsen CB, Starklint J, Clausen MR, Pedersen PT, Juul MB, Severinsen MT, Bøgsted M, El-Galaly TC. No differential overall or relative survival effect of rituximab in male and female patients with diffuse large B-cell lymphoma: a Danish population-based study of 3783 patients. Leuk Lymphoma. 2019 May 6:1-4. doi:
    10.1080/10428194.2019.1602264. [Epub ahead of print] PubMed PMID: 31057011.
  11. Biccler JL, Savage KJ, Brown PDN, Jørgensen J, Larsen TS, Poulsen CB, Stoltenberg D, Sehn LH, Scott DW, Gerrie AS, Jakobsen LH, Bøgsted M, El-Galaly TC, Villa D. Risk of death, relapse or progression, and loss of life expectancy at different progression-free survival milestones in primary central nervous system lymphoma. Leuk Lymphoma. 2019 Apr 3:1-8. doi: 10.1080/10428194.2019.1594219. [Epub ahead of print] PubMed PMID: 30943052.
  12. Binkley MS, Brady JL, Hajj C, Chelius M, Chau K, Balogh A, Levis M, Filippi AR, Jones M, Ahmed S, MacManus M, Wirth A, Oguchi M, Vistisen AK, Andraos TY, Ng AK, Aleman BMP, Choi SH, Kirova YM, Hardy S, Reinartz G, Eich HT, Bratman SV, Constine LS, Suh CO, Dabaja B, El-Galaly TC, Hodgson DC, Ricardi U, Yahalom J, Mikhaeel NG, Hoppe RT. Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG. Int J Radiat Oncol Biol Phys. 2019 Mar 8. pii: S0360-3016(19)30317-7. doi: 10.1016/j.ijrobp.2019.03.004. [Epub ahead of print] PubMed PMID: 30858143.
  13. Nørgaard JM, Friis LS, Kristensen JS, Severinsen MT, Mølle I, Marcher CW, Møller P, Schoellkopf C, Nielsen OJ, Preiss BS, Andersen MK, Kjeldsen E, Medeiros BC, Østgård LSG; Danish Acute Leukemia Group. Addressing the room for improvement in management of acute promyelocytic leukemia. Eur J Haematol. 2019 Mar 19. doi: 10.1111/ejh.13229. [Epub ahead of print] PubMed PMID: 30887583.
  14. Roug AS, Ommen HB. Clinical Use of Measurable Residual Disease in Acute Myeloid Leukemia. Curr Treat Options Oncol. 2019 Mar 14;20(4):28. doi: 10.1007/s11864-019-0627-4. Review. PubMed PMID: 30874904.
  15. Bill M, Aggerholm A, Kjeldsen E, Roug AS, Hokland P, Nederby L. Revisiting CLEC12A as leukaemic stem cell marker in AML: highlighting the necessity of precision diagnostics in patients eligible for targeted therapy. Br J Haematol. 2019 Mar;184(5):769-781. doi: 10.1111/bjh.15711. Epub 2018 Dec 5. PubMed PMID: 30520015.
  16. Due H, Schönherz AA, Ryø L, Primo MN, Jespersen DS, Thomsen EA, Roug AS, Xiao M, Tan X, Pang Y, Young KH, Bøgsted M, Mikkelsen JG, Dybkær K. MicroRNA-155 controls vincristine sensitivity and predicts superior clinical outcome in diffuse large B-cell lymphoma. Blood Adv. 2019 Apr 9;3(7):1185-1196. doi: 10.1182/bloodadvances.2018029660. PubMed PMID: 30967394; PubMed Central PMCID: PMC6457225.
  17. Skau Rasmussen L, Vittrup B, Ladekarl M, Pfeiffer P, Karen Yilmaz M, Østergaard Poulsen L, Østerlind K, Palnæs Hansen C, Bau Mortensen M, Viborg Mortensen F, Sall M, Detlefsen S, Bøgsted M, Wilki Fristrup C. The effect of postoperative gemcitabine on overall survival in patients with resected pancreatic cancer: A nationwide population-based Danish register study. Acta Oncol. 2019 Mar 25:1-8. doi: 10.1080/0284186X.2019.1581374. [Epub ahead of print] PubMed PMID: 30905248.
  18. Chin CK, Tsang E, Mediwake H, Khair W, Biccler J, Hapgood G, Mollee P, Nizich Z, Joske D, Radeski D, Cull G, Villa D, El-Galaly TC, Cheah CY. Frequency of bowel perforation and impact of bowel rest in aggressive non-Hodgkin lymphoma with gastrointestinal involvement. Br J Haematol. 2019 Mar;184(5):826-828. doi: 10.1111/bjh.15173. Epub 2018 Apr 20. PubMed PMID: 29676487.
  19. Jafari A, Isa A, Chen L, Ditzel N, Zaher W, Harkness L, Johnsen HE, Abdallah BM, Clausen C, Kassem M. TAFA2 Induces Skeletal (Stromal) Stem Cell Migration Through Activation of Rac1-p38 Signaling. Stem Cells. 2019 Mar;37(3):407-416. doi: 10.1002/stem.2955. Epub 2018 Dec 17. PubMed PMID: 30485583.
  20. Xu-Monette Z, Xiao M, Au Q, Padmanabhan R, Xu B, Hoe N, Rodriguez-Perales S, Torres-Ruiz R, Manyam G, Visco C, Miao Y, Tan X, Zhang H, Tzankov A, Wang J, Dybkaer K, Tam W, You H, Bhagat G, Hsi ED, Ponzoni M, Ferreri AJM, Møller MB, Piris MA, van Krieken JH, Winter JN, Westin JR, Pham LV, Medeiros LJ, Rassidakis GZ, Li Y, Freeman GJ, Young KH. Immune profiling and quantitative analysis decipher the clinical role of immune checkpoint expression in the tumor immune microenvironment of DLBCL. Cancer Immunol Res. 2019 Feb 11. pii: canimm.0439.2018. doi: 10.1158/2326-6066.CIR-18-0439. [Epub ahead of print] PubMed PMID: 30745366.
  21. Laursen MB, Reinholdt L, Schönherz AA, Due H, Jespersen DS, Grubach L, Ettrup MS, Røge R, Falgreen S, Sørensen S, Bødker JS, Schmitz A, Johnsen HE, Bøgsted M, Dybkær K. High CXCR4 expression impairs rituximab response and the prognosis of R-CHOP-treated diffuse large B-cell lymphoma patients. Oncotarget. 2019 Jan 22;10(7):717-731. doi: 10.18632/oncotarget.26588. eCollection 2019 Jan 22. PubMed PMID: 30774774; PubMed Central PMCID: PMC6366826.
  22. Panou V, Vyberg M, Meristoudis C, Hansen J, Bøgsted M, Omland Ø, Weinreich UM, Røe OD. Non-occupational exposure to asbestos is the main cause of malignant mesothelioma in women in North Jutland, Denmark. Scand J Work Environ Health. 2019 Jan 1;45(1):82-89. doi: 10.5271/sjweh.3756. Epub 2018 Jul 19. PubMed PMID: 30025147.
  23. Brady JL, Binkley MS, Hajj C, Chelius M, Chau K, Balogh A, Levis M, Filippi AR, Jones M, Mac Manus M, Wirth A, Oguchi M, Vistisen AK, Andraos TY, Ng AK, Aleman BMP, Choi SH, Kirova Y, Hardy S, Reinartz G, Eich HT, Bratman SV, Constine LS, Suh CO, Dabaja B, El-Galaly TC, Hodgson DC, Ricardi U, Yahalom J, Hoppe RT, Mikhaeel NG. Definitive radiotherapy for localized follicular lymphoma staged by (18)F-FDG PET-CT: a collaborative study by ILROG. Blood. 2019 Jan 17;133(3):237-245. doi: 10.1182/blood-2018-04-843540. Epub 2018 Nov 16.
    PubMed PMID: 30446493.
  24. Li L, Sun R, Miao Y, Tran T, Adams L, Roscoe N, Xu B, Manyam GC, Tan X, Zhang H, Xiao M, Tzankov A, Visco C, Dybkaer K, Bhagat G, Tam W, Hsi ED, van Krieken JH, You H, Huh J, Ponzoni M, Ferreri AJM, Møller MB, Piris MA, Zhang M, Winter JN, Medeiros LJ, Rassidakis GZ, Vaupel CA, Li Y, Dakappagari N, Xu-Monette ZY, Young KH. PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the
    International DLBCL Consortium Program. Mod Pathol. 2019 Jan 21. doi: 10.1038/s41379-018-0193-5. [Epub ahead of print] PubMed PMID: 30666052.
  25. Jespersen DS, Schönherz AA, Due H, Bøgsted M, Sondergaard TE, Dybkær K. Expression of NOTCH3 exon 16 differentiates Diffuse Large B-cell Lymphoma into molecular subtypes and is associated with prognosis. Sci Rep. 2019 Jan 23;9(1):335. doi: 10.1038/s41598-018-36680-x. PubMed PMID: 30674940; PubMed Central PMCID: PMC6344585.
  26. Jakobsen LH, Andersson TM, Biccler JL, El-Galaly TC, Bøgsted M. Estimating the loss of lifetime function using flexible parametric relative survival models. BMC Med Res Methodol. 2019 Jan 28;19(1):23. doi: 10.1186/s12874-019-0661-8. PubMed PMID: 30691400; PubMed Central PMCID: PMC6350283.
  27. Biccler JL, Glimelius I, Eloranta S, Smeland KB, Brown PN, Jakobsen LH, Frederiksen H, Jerkeman M, Fosså A, Andersson TML, Holte H, Bøgsted M, El-Galaly TC, Smedby KE. Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group Study. J Clin Oncol. 2019 Feb 6:JCO1801652. doi: 10.1200/JCO.18.01652. [Epub ahead of print] PubMed PMID: 30726176.

 

NEXT Bioinformatics Activity Report 2015-2018

 

Publikationer 2018

 Publications 2017

Publications 2016

Publications 2015

Publications 2014

Publications 2013

Publications 2012

Publications 2011

Publications 2010

Publications 2009 – 2004